×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
Stablepharma Launches Phase 1 Trials for First-Ever Fridge-Free Tetanus & Diphtheria Vaccine
BioCryst shares real-world data highlighting strong adherence and persistence with ORLADEYO® (berotralstat)
24 Oct 2024
BioCryst Pharmaceuticals, Inc. announced new real-world comparative research on the use of oral,
...
S&E Bio Secures Korea’s First Approval for a Clinical Trial of Exosome-Based Therapy
With New Offerings Like MIC+B12 Injections, Metformin Combinations, and More, Shed Expands Its Weight Management Support
Abzena Launches LabZient™, an Analytical Platform to Expedite the Path to IND for Antibodies
Aptar Pharma Launched Premia™ Precision, Establishing a New Quality Standard for Demanding Injectable Therapies
Alchemy 21/12 Introduces Oleotide™, a Breakthrough Modular Biotechnology Platform for Advanced Skincare
By
Alchemy 21/12
Alchemy 21/12
28 Oct 2026
CELSET Launches Korean Botulinum Toxin Type A Brand SOLTOX in International Markets
By
CELSET INC
CELSET INC
28 Oct 2026
SEKISUI Diagnostics Announces 510(k) Clearance and Launches the OSOM® COVID-19/Flu A&B Combo Test
By
SEKISUI DIAGNOSTICS, LLC
SEKISUI DIAGNOSTICS, LLC
27 Oct 2026
Stevanato Group and Aptar Pharma Collaborate to Accelerate Pre-Filled Syringe System Selection
By
Stevanato Group S.p.A.
Stevanato Group S.p.A.
27 Oct 2026
Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets
By
Pythia Labs
Pythia Labs
27 Oct 2026
Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets
By
Pythia Labs
Pythia Labs
27 Oct 2026
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
Constance Sabbagh Appointed as General Manager as Avanzanite Expands French Operations
By
Avanzanite Bioscience B.V.
Mar 24
Cardurion Pharmaceuticals has named Charlotte Newman as Chief Business Officer
By
Cardurion Pharmaceuticals, Inc.
Jan 08
New FDA-Cleared Treatment for Fibromyalgia Symptoms from Swing Therapeutics Covered by Highmark
By
Swing Therapeutics
Feb 06
October
2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe to Our Monthly Newsletter
Subscribe to Pharmaceutical Era’s monthly newsletter,
Pharmaceutical Leaders Digest
®, to receive timely updates from across the pharmaceutical industry.
I agree with the
Terms and conditions
×
and the
Privacy policy
×
Please enable the javascript to submit this form
Subscribe
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand